BIOVIC B — Biovica International AB Balance Sheet
0.000.00%
- SEK86.11m
- SEK40.55m
- SEK13.38m
Annual balance sheet for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 89.8 | 114 | 79.4 | 24.4 | 70.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.98 | 1.54 | 3.33 | 2.32 | 5.57 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 94.9 | 120 | 88.1 | 30.8 | 80.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13.6 | 11.2 | 8.11 | 4.77 | 4.42 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 152 | 172 | 131 | 64.9 | 108 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.1 | 23.6 | 28.3 | 18.2 | 18.7 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 27.5 | 33.7 | 34.8 | 21.7 | 21.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 124 | 139 | 96.6 | 43.2 | 86.3 |
| Total Liabilities & Shareholders' Equity | 152 | 172 | 131 | 64.9 | 108 |
| Total Common Shares Outstanding |